Cargando…

Establishment of a molecular cytogenetic analysis for native tumor tissue of meningiomas-suitable for clinical application

BACKGROUND: Meningiomas are mostly benign tumors which arise from the meninges. They are among the cytogenetically best-studied solid tumors, mostly displaying a normal karyotype or, as a typical primary aberration, monosomy of chromosome 22. Further secondary chromosomal aberrations, especially the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lerner, Cornelia, Ketter, Ralf, Linsler, Stefan, Henn, Wolfram, Oertel, Joachim, Urbschat, Steffi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937053/
https://www.ncbi.nlm.nih.gov/pubmed/24499596
http://dx.doi.org/10.1186/1755-8166-7-12
_version_ 1782305419509628928
author Lerner, Cornelia
Ketter, Ralf
Linsler, Stefan
Henn, Wolfram
Oertel, Joachim
Urbschat, Steffi
author_facet Lerner, Cornelia
Ketter, Ralf
Linsler, Stefan
Henn, Wolfram
Oertel, Joachim
Urbschat, Steffi
author_sort Lerner, Cornelia
collection PubMed
description BACKGROUND: Meningiomas are mostly benign tumors which arise from the meninges. They are among the cytogenetically best-studied solid tumors, mostly displaying a normal karyotype or, as a typical primary aberration, monosomy of chromosome 22. Further secondary chromosomal aberrations, especially the deletion of chromosome 1p, are correlated with increasing biological aggressiveness up to malignancy. These data are derived from the cytogenetical characterization of 661 meningiomas, from which the genetic progression score (GPS) has been developed. Due to the high expenditure of time and the expert knowledge for the cytogenetical characterization, the aim of this work was to establish an equally reliable yet more rapid clinical diagnosis based on fluorescence in situ hybridization (FISH) on meningiomas. Thus a comparison between the native tumor tissue and the primary culture of the same tumor was done in order to determine the most efficient method for a molecular cytogenetic characterization. The diagnostic procedure has to deliver fast and robust results, since they must enable the attending physician to plan the appropriate follow-up regimens for the patients. All in all, preparations of native tumor tissue as well as preparations of cell culture of 22 meningiomas were tested with FISH for aberrations concerning the prognostically relevant chromosome regions 1p and 9p, and the chromosomes 10, 14, 18 and 22 in comparison with the particular karyotypes revealed by conventional karyotyping using G-banding. RESULTS: The FISH examinations between native and cultured cells showed an accordance of 93.4%. The comparison of FISH data and karyotyping presented accordance to the greatest possible extent concerning the chromosomes 14, 18 and 22, but to detect the progression associated losses of 1p and 9p FISH is the most sensitive method. CONCLUSIONS: The raised data reveal that both methods can be used for a significant analysis of chromosome aberrations on meningiomas. As a result of that the complex primary culture could also be avoided. Therefore a clinical diagnosis based on FISH on meningiomas is at hand for the assignment of patients to a suitable follow-up regimen.
format Online
Article
Text
id pubmed-3937053
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39370532014-02-28 Establishment of a molecular cytogenetic analysis for native tumor tissue of meningiomas-suitable for clinical application Lerner, Cornelia Ketter, Ralf Linsler, Stefan Henn, Wolfram Oertel, Joachim Urbschat, Steffi Mol Cytogenet Research BACKGROUND: Meningiomas are mostly benign tumors which arise from the meninges. They are among the cytogenetically best-studied solid tumors, mostly displaying a normal karyotype or, as a typical primary aberration, monosomy of chromosome 22. Further secondary chromosomal aberrations, especially the deletion of chromosome 1p, are correlated with increasing biological aggressiveness up to malignancy. These data are derived from the cytogenetical characterization of 661 meningiomas, from which the genetic progression score (GPS) has been developed. Due to the high expenditure of time and the expert knowledge for the cytogenetical characterization, the aim of this work was to establish an equally reliable yet more rapid clinical diagnosis based on fluorescence in situ hybridization (FISH) on meningiomas. Thus a comparison between the native tumor tissue and the primary culture of the same tumor was done in order to determine the most efficient method for a molecular cytogenetic characterization. The diagnostic procedure has to deliver fast and robust results, since they must enable the attending physician to plan the appropriate follow-up regimens for the patients. All in all, preparations of native tumor tissue as well as preparations of cell culture of 22 meningiomas were tested with FISH for aberrations concerning the prognostically relevant chromosome regions 1p and 9p, and the chromosomes 10, 14, 18 and 22 in comparison with the particular karyotypes revealed by conventional karyotyping using G-banding. RESULTS: The FISH examinations between native and cultured cells showed an accordance of 93.4%. The comparison of FISH data and karyotyping presented accordance to the greatest possible extent concerning the chromosomes 14, 18 and 22, but to detect the progression associated losses of 1p and 9p FISH is the most sensitive method. CONCLUSIONS: The raised data reveal that both methods can be used for a significant analysis of chromosome aberrations on meningiomas. As a result of that the complex primary culture could also be avoided. Therefore a clinical diagnosis based on FISH on meningiomas is at hand for the assignment of patients to a suitable follow-up regimen. BioMed Central 2014-02-05 /pmc/articles/PMC3937053/ /pubmed/24499596 http://dx.doi.org/10.1186/1755-8166-7-12 Text en Copyright © 2014 Lerner et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Lerner, Cornelia
Ketter, Ralf
Linsler, Stefan
Henn, Wolfram
Oertel, Joachim
Urbschat, Steffi
Establishment of a molecular cytogenetic analysis for native tumor tissue of meningiomas-suitable for clinical application
title Establishment of a molecular cytogenetic analysis for native tumor tissue of meningiomas-suitable for clinical application
title_full Establishment of a molecular cytogenetic analysis for native tumor tissue of meningiomas-suitable for clinical application
title_fullStr Establishment of a molecular cytogenetic analysis for native tumor tissue of meningiomas-suitable for clinical application
title_full_unstemmed Establishment of a molecular cytogenetic analysis for native tumor tissue of meningiomas-suitable for clinical application
title_short Establishment of a molecular cytogenetic analysis for native tumor tissue of meningiomas-suitable for clinical application
title_sort establishment of a molecular cytogenetic analysis for native tumor tissue of meningiomas-suitable for clinical application
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937053/
https://www.ncbi.nlm.nih.gov/pubmed/24499596
http://dx.doi.org/10.1186/1755-8166-7-12
work_keys_str_mv AT lernercornelia establishmentofamolecularcytogeneticanalysisfornativetumortissueofmeningiomassuitableforclinicalapplication
AT ketterralf establishmentofamolecularcytogeneticanalysisfornativetumortissueofmeningiomassuitableforclinicalapplication
AT linslerstefan establishmentofamolecularcytogeneticanalysisfornativetumortissueofmeningiomassuitableforclinicalapplication
AT hennwolfram establishmentofamolecularcytogeneticanalysisfornativetumortissueofmeningiomassuitableforclinicalapplication
AT oerteljoachim establishmentofamolecularcytogeneticanalysisfornativetumortissueofmeningiomassuitableforclinicalapplication
AT urbschatsteffi establishmentofamolecularcytogeneticanalysisfornativetumortissueofmeningiomassuitableforclinicalapplication